- Report
- May 2024
- 128 Pages
Global
From €5754EUR$6,499USD£4,983GBP
- Report
- March 2024
- 124 Pages
North America
From €2655EUR$2,999USD£2,300GBP
- Report
- May 2023
- 123 Pages
Global
From €5268EUR$5,950USD£4,562GBP
- Report
- June 2025
- 200 Pages
Australia
From €2205EUR$2,490USD£1,909GBP
- Report
- January 2019
- 30 Pages
China
From €1948EUR$2,200USD£1,687GBP
- Report
- September 2018
- 30 Pages
China
From €1948EUR$2,200USD£1,687GBP
- Report
- March 2024
- 150 Pages
Global
From €2877EUR$3,250USD£2,492GBP
€4294EUR$4,850USD£3,719GBP
- Report
- January 2024
- 150 Pages
Global
From €2877EUR$3,250USD£2,492GBP
€4294EUR$4,850USD£3,719GBP
- Report
- January 2024
- 150 Pages
Global
From €2877EUR$3,250USD£2,492GBP
€4294EUR$4,850USD£3,719GBP
- Report
- January 2024
- 150 Pages
Global
From €2877EUR$3,250USD£2,492GBP
€4294EUR$4,850USD£3,719GBP
- Report
- January 2024
- 161 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- November 2021
- 120 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- May 2022
- 38 Pages
Global
From €1771EUR$2,000USD£1,534GBP
- Report
- August 2022
- 120 Pages
Global
From €3984EUR$4,500USD£3,451GBP
- Report
- November 2021
- 109 Pages
Global
From €3984EUR$4,500USD£3,451GBP
- Report
- August 2024
- 82 Pages
Japan
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- June 2024
- 180 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- October 2023
- 190 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- May 2024
- 133 Pages
Global
From €5754EUR$6,499USD£4,983GBP
- Report
- May 2024
- 128 Pages
Global
From €5754EUR$6,499USD£4,983GBP

The Sexual and Reproductive Health Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and treatments related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, erectile dysfunction, and contraception. They also include treatments for sexually transmitted infections, such as HIV and HPV.
The market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include Pfizer, Merck, Bayer, and GSK. These companies are involved in the research and development of new drugs and treatments, as well as the marketing and distribution of existing products. Other companies in the market include Allergan, Teva, and Mylan. Show Less Read more